Skip to main content

Table 1 Demographic and clinical characteristics of the patients (N = 104)

From: Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital

Characteristics

N (%)

Gender

Female

48 (46.2)

Age

< 65

69 (66.3)

≥ 65

35 (33.7)

Dialysis type

HD

56 (53.8)

PD

48 (46.2)

ESKD etiology

Hypertensive nephropathy

21 (20.2)

Diabetic nephropathy

19 (18.3)

Polycystic kidney diseases

3 (2.9)

Glomerulonephritis

2 (1.9)

Obstructive nephropathy

2 (1.9)

Amyloidosis

1 (0.9)

Miscellaneous

24 (23.1)

Unknown etiology

32 (30.8)

Comorbidities

 

Hypertension

66 (63.5)

Diabetes

24 (23.1)

Cardiovascular disease

16 (15.4)

Dyslipidemia

11 (10.6)

Number of comorbidities

0

23 (22.1)

1

39 (37.5)

2

19 (18.3)

3 or more

23 (22.1)

Number of drugs

1–5

22 (21.2)

6–10

69 (66.3)

11–15

13 (12.5)

Laboratory findings, mean ± SD

Glucose (mg/dL)

127.5 ± 110.9

Bicarbonate (mmol/L)

21.7 ± 4.1

Hb (g/dL)

11.2 ± 1.7

HbA1c (%)

6.7 ± 1.9

Ferritin (ng/mL)

580.3 ± 725.0

Transferrin (mg/dL)

30.5 ± 15.6

Potassium (mmol/L)

4.2 ± 0.7

Phosphorus (mg/dL)

5.0 ± 1.4

Calcium (mg/dL)

8.8 ± 0.7

Vitamin D (nmol/L)

11.5 ± 7.0

Parathormone (pg/mL)

481.7 ± 469.9

LDL-cholesterol (mg/dL)

92.6 ± 37.2

  1. ESKD End Stage Kidney Disease, Hb Hemoglobin, LDL Low-density lipoprotein, SD Standard deviation